Prospect News: News for Albany Molecular Research, Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

User:

Log out

Prospect News home > Main news index > All issuers starting with A > All stories on Albany Molecular Research, Inc.

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Albany Molecular Research, Inc.

7/19/2021	BK	S&P shifts Curia Global view to negative
7/16/2021	BK	Moody's cuts Curia, gives B2 to add-on
4/19/2021	BK	S&P ups Albany Molecular
10/27/2020	BK	Albany Molecular allocates first-lien term loan at Libor plus 350 bps
10/22/2020	CLHY	Market Commentary: Hyperion, Help at Home, Adevinta, Sovos break; Barracuda, Albany Molecular update deals
10/22/2020	BK	Market Commentary: Hyperion, Help at Home, Adevinta, Sovos break; Barracuda, Albany Molecular update deals
10/22/2020	BK	Albany Molecular flexes $210 million term loan to Libor plus 350 bps
10/21/2020	CLHY	Market Commentary: Rough Country breaks; Adevinta, Sovos updated; PAI, Barracuda, Albany Molecular accelerated
10/21/2020	BK	Market Commentary: Rough Country breaks; Adevinta, Sovos updated; PAI, Barracuda, Albany Molecular accelerated
10/19/2020	CLHY	Market Commentary: Quirch, Mega Broadband break; Chobani tweaks deal; MultiPlan, Les Schwab and more set talk
10/19/2020	BK	Market Commentary: Quirch, Mega Broadband break; Chobani tweaks deal; MultiPlan, Les Schwab and more set talk
10/19/2020	BK	Moody’s ups Albany Molecular rates facility B2
10/19/2020	BK	S&P gives Albany Molecular loan B-
10/19/2020	BK	Albany Molecular talks $210 million term loan at Libor plus 375 bps
10/16/2020	CLHY	Market Commentary: 1-800 Contacts frees up; Filtration Group, Mega Broadband, Ascend Learning changes emerge
10/16/2020	BK	Market Commentary: 1-800 Contacts frees up; Filtration Group, Mega Broadband, Ascend Learning changes emerge
10/16/2020	BK	Albany Molecular to launch $210 million term loan on Monday
8/31/2020	BK	S&P shifts Albany Molecular view to stable
6/26/2019	BK	S&P downgrades Albany Research
6/20/2018	BKCV	S&P changes Albany Molecular view
7/28/2017	BK	Market Commentary: Heartland, Avast, EnergySolutions, Albany Molecular, Culligan, Victory, FleetCor break
7/28/2017	CLHY	Market Commentary: Heartland, Avast, EnergySolutions, Albany Molecular, Culligan, Victory, FleetCor break
7/27/2017	CLHY	Market Commentary: CareerBuilder, Flying Fortress, J.D. Power break; GNC term loan rises on quarterly numbers
7/27/2017	BK	Market Commentary: CareerBuilder, Flying Fortress, J.D. Power break; GNC term loan rises on quarterly numbers
7/27/2017	BKCV	S&P lowers Albany Molecular’s first-lien loans
7/27/2017	BK	Albany Molecular upsizes first-lien term loan, tightens pricing
7/24/2017	CLHY	Market Commentary: Zebra, Peak 10, YRC break; Diversey, Duravant, CPI, U.S. Security, Sky Betting set changes
7/24/2017	BK	Market Commentary: Zebra, Peak 10, YRC break; Diversey, Duravant, CPI, U.S. Security, Sky Betting set changes
7/19/2017	CLHY	Market Commentary: Cypress, Arterra, Midcontinent break; HD Supply Waterworks, CPM, Interface tweak deals
7/19/2017	BK	Market Commentary: Cypress, Arterra, Midcontinent break; HD Supply Waterworks, CPM, Interface tweak deals
7/19/2017	BKCV	Moody’s: UIC Merger/Albany Molecular facilities B2, Caa2
7/19/2017	BK	Albany Molecular discloses first- and second-lien term loan price talk
7/19/2017	BKCV	S&P: Albany Molecular loans B+, B-
7/17/2017	CLHY	Market Commentary: Zebra trades a touch lower with repricing; near-term new issue calendar continues to build
7/17/2017	BK	Market Commentary: Zebra trades slightly lower with repricing; near-term new issue calendar continues to build
7/17/2017	BK	Albany Molecular to launch $925 million credit facilities on Wednesday
7/5/2017	BK	Albany Molecular plans $960 million credit facilities for buyout
6/7/2017	BKCV	S&P might lower Albany Molecular
6/6/2017	BK	Albany Molecular plans new debt for buyout by Carlyle and GTCR
2/21/2017	CV	Market Commentary: Holiday weighs on convertible bond volume; primary calendar builds; Vipshop firms
12/20/2016	BKDDHY	S&P acts on U.S. pharmaceuticals
6/6/2016	CLHY	Market Commentary: Generation Brands, Albany Molecular update deals; primary activity continues to blossom
6/6/2016	BK	Market Commentary: Generation Brands, Albany Molecular update deals; primary activity continues to blossom
6/6/2016	BK	Albany Molecular firms discount on $230 million add-on term loan at 99
5/24/2016	CLHY	Market Commentary: Verisk Health breaks; TransDigm dips with acquisition news; BMC Software trades higher
5/24/2016	BK	Market Commentary: Verisk Health breaks; TransDigm dips with acquisition news; BMC Software trades higher
5/24/2016	BK	Albany Molecular launches $230 million add-on term loan to investors
5/11/2016	BKCVDD	S&P lowers Albany Molecular loans to B
5/6/2016	BK	Albany Molecular gets commitment for planned Euticals acquisition
8/19/2015	CLHY	Market Commentary: US LBM frees to trade; KIK Custom Products modifies loan; Townsquare moves up deadline
8/19/2015	BK	Market Commentary: US LBM frees to trade; KIK Custom Products modifies loan; Townsquare moves up deadline
8/14/2015	BK	Market Commentary: CPI Card, Duff & Phelps, Hudson’s Bay, Patterson, Albany Molecular break; Avago tweaks deal
8/14/2015	CLHY	Market Commentary: CPI Card, Duff & Phelps, Hudson’s Bay, Patterson, Albany Molecular break; Avago tweaks deal
8/14/2015	BK	Market Commentary: CPI Card, Duff & Phelps, Patterson Medical, Albany Molecular break; Avago tweaks deals
8/13/2015	CLHY	Market Commentary: Owens-Brockway Glass, Knowledge Universe, AMAG Pharmaceuticals, Vistage, USI free to trade
8/13/2015	BK	Market Commentary: Owens-Brockway Glass, Knowledge Universe, AMAG Pharmaceuticals, Vistage, USI free to trade
7/29/2015	CLHY	Market Commentary: Hostess, Jarden, Peacock Engineering, Precyse, Ascena Retail, EagleView Technology break
7/29/2015	BK	Market Commentary: Hostess, Jarden, Peacock Engineering, Precyse, Ascena Retail, EagleView Technology break
7/29/2015	BK	Albany Molecular launches $200 million term B at Libor plus 475 bps
7/27/2015	BK	Market Commentary: Alliant Insurance, Universal Services, Numericable break; Hostess, Jarden changes revealed
7/27/2015	CLHY	Market Commentary: Alliant Insurance, Universal Services, Numericable break; Hostess, Jarden changes revealed
7/27/2015	BKCV	Moody’s rates Albany Molecular CFR B3, loans B1
7/27/2015	BK	Albany Molecular to launch $230 million credit facility on Wednesday
7/24/2015	BKCVDD	S&P rates Albany Molecular loans B+, convertibles CCC+
7/16/2015	BK	Albany Molecular obtains $200 million term loan, $30 million revolver
12/30/2014	BK	Albany Molecular lifts three-year revolver commitments to $75 million
1/21/2014	CV	Market Commentary: NQ Mobile, Teva Pharmaceutical better on swap; Yandex in trade; YRC Worldwide in focus
12/4/2013	CV	Albany Molecular greenshoe lifts 2.25% convertibles to $150 million
11/20/2013	CV	New Issue: Albany Molecular sells upsized $130 million five-year convertibles at 2.25%, up 32%
11/20/2013	CV	Market Commentary: Blackstone adds on hedge; new Cardtronics, Albany Molecular slip; Yahoo! upsizes; WebMD on tap
11/20/2013	CV	Market Commentary: Midday Commentary: New Cardtronics, Albany Molecular hover near par; Yahoo! offering in focus
11/19/2013	CV	Albany Molecular plans $100 million five-year convertibles to yield 2%-2.5%, up 27.5%-32.5%
11/19/2013	CV	Market Commentary: New Energy XXI trades around par; new Horizon Pharma surges with shares; Yahoo! to price
12/22/2011	CVPF	Albany Molecular Research files $50 million stock, preferreds shelf
8/3/2006	BT	Jefferies cuts Albany Molecular target
5/18/2006	BT	Albany Molecular breaks ground on new R&D center in India
5/10/2006	BT	Albany on hold by Jefferies
2/14/2006	BT	Albany Molecular at hold by Jefferies
2/8/2006	BT	Jefferies raises Albany Molecular to hold
1/30/2006	BT	Jefferies rates Albany at underperform
1/30/2006	BT	Albany Molecular agrees to purchase Hungarian drug research company
11/4/2005	BT	Jefferies keeps Albany Molecular at underperform
10/24/2005	BT	Jefferies maintains Albany Molecular at market underperform
10/14/2005	BT	Clinical trial demand makes early-stage biotech contract researchers look interesting, Jefferies says
9/6/2005	BT	Albany downgraded by Jefferies to underperform
8/5/2005	BT	Albany price target raised by Jefferies
7/7/2005	BT	Albany Molecular Research amends revolver, extending maturity to 2010

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.